Literature DB >> 21988204

Subclinical Cushing's syndrome: definition and management.

M Terzolo1, A Pia, G Reimondo.   

Abstract

Subclinical Cushing's syndrome is an ill-defined endocrine disorder that may be observed in patients bearing an incidentally found adrenal adenoma. The concept of subclinical Cushing's syndrome stands on the presence of ACTH-independent cortisol secretion by an adrenal adenoma, that is not fully restrained by pituitary feed-back. A hypercortisolemic state of usually minimal intensity may ensue and eventually cause harm to the patients in terms of metabolic and vascular diseases, and bone fractures. However, the natural history of subclinical Cushing's syndrome remains largely unknown. The present review illustrates the currently used methods to ascertain the presence of subclinical Cushing's syndrome and the surrounding controversy. The management of subclinical Cushing's syndrome, that remains a highly debated issue, is also addressed and discussed. Most of the recommendations made in this chapter reflects the view and the clinical experience of the Authors and are not based on solid evidence.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 21988204     DOI: 10.1111/j.1365-2265.2011.04253.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  21 in total

1.  Practical evaluation of late-night salivary cortisol: a real-life approach.

Authors:  Zhanna E Belaya; Galina A Melnichenko
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Subclinical hypercortisolism: debatable or visible on the lightbox?

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

3.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

4.  Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing's syndrome in patients with bilateral adrenal disease.

Authors:  Aoife J Lowery; Barbara Seeliger; Pier F Alesina; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2017-02-28       Impact factor: 3.445

5.  The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism.

Authors:  Maria Pia Ricciato; Vincenzo Di Donna; Germano Perotti; Alfredo Pontecorvi; Rocco Bellantone; Salvatore M Corsello
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 6.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

7.  Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.

Authors:  Luigi Petramala; Giuseppe Cavallaro; Matteo Galassi; Cristiano Marinelli; Gianfranco Tonnarini; Antonio Concistrè; Umberto Costi; Maurizio Bufi; Piernatale Lucia; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-01-31

8.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

Authors:  Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio
Journal:  N Engl J Med       Date:  2014-02-26       Impact factor: 91.245

9.  Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome.

Authors:  Roberta Giordano; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Andreea Picu; Clizia Zichi; Beatrice Fussotto; Maria Manzo; Giulio Mengozzi; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

Review 10.  Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.

Authors:  Alan Kelsall; Ahmed Iqbal; John Newell-Price
Journal:  Gland Surg       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.